@FiercePharma: ICYMI yesterday: Will docs jump on new biosims? Survey shows they'll need some nudging. More | Follow @FiercePharma
@EricPFierce: Xellia decides it's best to have U.S. sales operations next to Raleigh, NC, plant it's expanding. ICYMI from FiercePharmaManufacturing | Follow @EricPFierce
@CarlyHFierce: Mylan hopes Disney can add new magic to its allergy-fighting kingdom. FiercePharmaMarketing story | Follow @CarlyHFierce
> Generics-maker Mylan ($MYL) confirmed that it had been sued by Johnson & Johnson's ($JNJ) Janssen unit for patent infringement, over its branded cancer drug Zytiga. Release
> The National Institute for Health and Care Excellence (NICE) issued new guidelines designed to crack down on overuse of antibiotics to combat resistance to the meds. Report
> Kythera Biopharmaceuticals, which is about to be acquired by Allergan ($AGN), asked European regulators to approve its double-chin injection, approved in the U.S. as Kybella. Release
> AMAG Pharmaceuticals ($AMAG) wrapped up its $700 million buyout of Cord Blood Registry. Release
Medical Device News
@FierceMedDev: UPDATED with comment from Fujifilm: FDA slaps three duodenoscope manufacturers with warning letters. Article | Follow @FierceMedDev
@EmilyWFierce: San Diego's Genalyte reeled in $44M in a Series C round for its microchip testing platform. Release | Follow @EmilyWFierce
> WSJ: New devices for rectal cancer surgery reduce need for colostomies. Story
> Illumina, LabCorp, Mayo Clinic, Warburg assemble to back latest consumer genomics entrant: Helix. Article
> FDA slaps three duodenoscope manufacturers with warning letters over related devices. Report
Biotech News
@FierceBiotech: ICYMI: Kite CEO Arie Belldegrun has a simple message for investors this morning: Relax. Story | Follow @FierceBiotech
@JohnCFierce: No surprise, coming off a $70M crossover, RegenX Bio files $100M. S-1/Report | Follow @JohnCFierce
> Omeros soars on fresh promise for its rare disease treatment. More
> Wave LifeSci banks $66M with a 'pure' take on synthetic chemistry. Story
> Edge Therapeutics swings for a $115M IPO with eyes on Phase III. Article
> Esperion surges after FDA offers a shot at quick approval for LDL-lowering drug. Report
Drug Delivery News
> BioDelivery snags new FDA approval for Onsolis after ditching Meda partnership. More
> Hydrogels: Study shows use in ulcerative colitis and Army invests in wound healing research. Report
> Checkmate Pharma gets $20M in Series A to develop cancer candidate with VLP platform. Story
> Cannabics Pharma's extended-release medical marijuana capsules available in Colorado. Item
> Intersect's steroid-releasing implant meets its endpoint in bid for expanded indication. Article
Pharma Manufacturing News
> FDA castigates three Mylan sterile drug plants in warning letter. News
> Hemispherx says plant upgrade will allow it to return its genital wart treatment to market. Item
> GSK resumes production at plant where Legionella bacteria was detected. Report
> Merck manufacturing shedding another 2,600 jobs. Story
> Novo Nordisk looks at building its first U.S. insulin plant. Article
Pharma Asia News
> More scrutiny for Japanese duodenoscope makers on notification failures. Report
> India's Lee Pharma turned down on CL challenge to AZ's Onglyza. Item
> Does China yuan devaluation mean more downbeat pharma earnings? Article
> Japan's Mitsui buys stake in India top drug wholesaler Keimed. Story
> Going private for WuXi PharmaTech opens dealmaking options. More
And Finally... After recalling all its frozen desserts amid a deadly listeria outbreak, Blue Bell Creamery says it's ready to start selling ice cream again. Report